Ghana Vaccine Confidence Surges as 9 in 10 Trust Immunisation — 5 Powerful Findings Revealed

A groundbreaking nationwide survey on Ghana vaccine confidence has revealed that nine out of ten Ghanaians trust vaccines and overwhelmingly support the country’s ambitious plans to manufacture them locally, according to findings released by the National Vaccine Institute (NVI). The massive study, which surveyed 13,905 respondents across all 16 regions and 55 districts, is one of the largest vaccine perception studies ever conducted in Ghana.

The survey results paint a remarkably positive picture of Ghana vaccine confidence, with 89.7 per cent of respondents expressing trust in vaccines and 94.2 per cent believing in collective responsibility to ensure vaccine accessibility. However, the study also exposed a critical awareness gap: only 14.3 per cent of Ghanaians know about the country’s plans to begin local vaccine production ahead of the expected 2027 rollout.

Ghana Vaccine Confidence Remains Strong Despite Global Scepticism

While vaccine hesitancy has emerged as a growing public health concern globally, the NVI survey demonstrates that Ghana vaccine confidence remains remarkably resilient. The findings stand in stark contrast to trends in many developed nations, where misinformation campaigns and political polarisation have eroded public trust in immunisation programmes.

Dr Sodzi Sodzi-Tettey, Chief Executive Officer of the NVI, emphasised the significance of the findings. “Ghana has a strong foundation of vaccine confidence, but success depends on bridging the awareness and trust gap for locally manufactured vaccines,” he stated in a press release.

The survey found that 87.8 per cent of respondents trust doctors and nurses who administer vaccines, reflecting deep confidence in Ghana’s healthcare professionals. Many respondents also expressed trust in the Ghana Health Service and the Food and Drugs Authority (FDA), suggesting that institutional credibility remains a powerful asset for the country’s vaccination efforts.

This high level of Ghana vaccine confidence provides a solid foundation for the country’s transition toward local vaccine manufacturing. However, experts caution that trust alone is not sufficient — public awareness and understanding of locally produced vaccines must be significantly improved before the 2027 rollout.

Regional Disparities in Ghana Vaccine Confidence

Despite the overall positive findings, the survey revealed notable regional differences in Ghana vaccine confidence that demand targeted interventions. Urban regions such as Greater Accra, Ashanti, and Central recorded relatively lower vaccine acceptance despite having greater access to information, a paradox that has puzzled researchers.

Conversely, rural communities in northern Ghana and the Oti Region showed stronger levels of trust and acceptance. This pattern suggests that traditional community structures and direct engagement with healthcare workers may play a more significant role in building vaccine confidence than information access alone.

The regional disparities in Ghana vaccine confidence have important implications for the NVI’s planned nationwide awareness campaign. Strategies that work in rural northern Ghana may not be effective in urban Accra, requiring tailored approaches for different demographic and geographic contexts.

Respondents across all regions indicated that seeing Ghanaian scientists and local manufacturing facilities involved in vaccine production would significantly boost confidence in Ghana-made vaccines. This finding suggests that transparency and visibility of local production processes will be critical to the success of the 2027 rollout.

Barriers Threatening Ghana Vaccine Confidence and Uptake

While Ghana vaccine confidence levels are encouraging, the survey identified several practical barriers that could undermine vaccine uptake even among trusting populations. The cost of vaccines, long distances to vaccination centres, and concerns over storage and transportation systems — particularly cold-chain infrastructure in rural communities — were cited as significant obstacles.

These findings align with broader healthcare access challenges facing Ghana. The country’s health system, while making significant strides, continues to grapple with infrastructure gaps, particularly in underserved communities. The healthcare system’s capacity challenges extend beyond vaccination to affect maternal health, emergency care, and chronic disease management.

Dr Sodzi-Tettey stressed the need to strengthen vaccine storage and distribution systems to maintain public trust and ensure effective delivery nationwide. “What is needed now is targeted policy and communication strategies to address misinformation, cost barriers, and regional disparities to encourage uptake,” he said.

The NVI findings also highlighted the persistent threat of misinformation, which can rapidly erode even the strongest levels of Ghana vaccine confidence. In an era of social media and instant communication, false claims about vaccine safety can spread faster than official corrections, making proactive communication strategies essential.

Ghana Vaccine Confidence and the Path to Local Manufacturing

The strong Ghana vaccine confidence revealed by the survey comes at a pivotal moment for the country’s healthcare sector. Ghana is preparing to begin local vaccine production in 2027, part of the African Union’s Partnership for African Vaccine Manufacturing (PAVM), which aims to ensure that at least 60 per cent of vaccines used in Africa are produced locally by 2040.

Dr Sodzi-Tettey framed the initiative as more than a health security measure. “The planned production of locally manufactured vaccines in 2027 is not only about health security,” he said. “It is about national pride, scientific advancement, economic resilience, and Africa’s determination to take control of its health future.”

Ahead of the 2027 rollout, the NVI plans to launch a nationwide awareness and acceptance campaign. The initiative will focus on addressing misinformation, increasing public understanding of local vaccine production, and encouraging national support for the programme. The campaign is expected to involve government institutions, development partners, healthcare professionals, civil society organisations, community leaders, the private sector, and the media.

The survey provides important baseline data to guide behaviour-change interventions and communication strategies aimed at improving vaccine acceptance. With Ghana vaccine confidence already at record levels, the challenge now is translating that trust into active support for locally manufactured vaccines — a goal that could reshape Africa’s healthcare landscape for generations to come.

Source: MyJoyOnline